Get news on conferences, trials, symposium invites, and more. Sign up for updates
Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

Interventional Oncology & Embolization

Discover the products and technologies to help treat your patients and access the latest education, training, and support.

Most visited

We’re shaping the future of cancer care, together.​


Boston Scientific is advancing Interventional Oncology & Embolization through clinician-led innovation, robust evidence, and a portfolio of minimally invasive therapies and solutions.

Our commitment spans product development, education, and collaboration across multidisciplinary teams—helping you do more for patients, for medicine, for life. And your dedication inspires everything we do.

Watch how you push us forward. ​

Growing need for cancer care​

One in five people around the world will develop cancer in their lifetimes and diagnoses are predicted to increase in the coming decades. We’re passionate about advancing science, improving outcomes, and supporting the future of interventional oncology. 

Cancer is the 2nd leading cause of death in the US

>600K patients die every year

New annual cases to increase worldwide ​

From 20 to 35 million by 2050​

Patients are getting younger

Cancer diagnoses is rising in men and women under age 50

Systemic therapy is rarely a standalone solution

Referring physicians expect to increase combination therapy across all types of liver cancer

Products to address care complexities​

Our comprehensive selection of tools spans embolization, Y-90, and more. Each solution is designed with clinicians in mind and backed by robust evidence to meet the complexity of cancer care. ​


Unmatched clinical investment and collaboration​

Shaped by close collaboration with physicians and strengthened by clinical trials that expand indications, our minimally invasive therapies are built to meet the complexity of cancer care. Together, we’re expanding access, improving outcomes, and pushing the boundaries of what’s possible. ​

60K

Patients treated with BSC cancer therapies last year

25+

Trials globally in expanding indications

Value beyond product

As a true partner throughout all stages of your career, we support healthcare professionals holistically, beyond the procedure. We invest in medical education, collaborate with leading physicians, and engage across major professional societies to advance evidence-based medicine. Multidisciplinary teams are essential for integrated patient care, ensuring diverse expertise contributes to treatment that’s best for every patient, while our focus on health economics underscores the need to align clinical value with financial sustainability. ​


icon

~20

Resident & early career programs


  • Resident
  • Early career
  • Fellows
  • Peer to peer

 

icon

35

Physician interaction opportunities


  • SIR
  • GEST
  • SIO

*Key societies and conferences listed  

icon

600+

US physician engagements


  • Advisory boards
  • Clinical trials
  • R&D initiatives
  • Commercial initiatives

 

icon

9

Conferences & meetings


  • Direct to referrer
  • Patient education
icon of plus sign

4

Field reimbursement team members


  • Reimbursement & coding
  • Insurance verification
  • Prior authorization support

 


Education and training

The EDUCARE online platform makes healthcare education and training more relevant, more comprehensive, more personal, and more accessible. Register to access a library of procedural videos, case studies, training resources, and events.

alt text

Reimbursement resources 

Find coding and economic resources for health care practitioners and their partners.

Sign up for updates

Get news on conferences, trials, symposium invites, and more.